Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes

Roberto Piva, Elisa Pellegrino, Michela Mattioli, +10

Journal of Clinical Investigation

Cancer ResearchLymphoid NeoplasiaSignaling PathwayFunctional ValidationReceptor Tyrosine Kinase +12

Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms

Roberto Piva, Luca Agnelli, Elisa Pellegrino, +17

Journal of Clinical Oncology

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

Roberto Piva, Roberto Chiarle, Andrea D. Manazza, +8

Blood

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Irene Scarfò, Elisa Pellegrino, Elisabetta Mereu, +22

Blood

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

Luca Agnelli, Elisabetta Mereu, Elisa Pellegrino, +13

Blood

microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma

Cuiling Liu, Javeed Iqbal, Julie Teruya‐Feldstein, +19

Blood

TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression

Mylène Seux, Sylvain Peuget, Marie-Pierre Montero, +13

Oncogene

Tumor BiologyPancreatic CancerMedicineCancer Cell BiologySparc Expression +6

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies

Elisa Bergaggio, Chiara Riganti, Giulia Garaffo, +16

Blood

ALK-Dependent Control of Hypoxia-Inducible Factors Mediates Tumor Growth and Metastasis

Cinzia Martinengo, Teresa Poggio, Matteo Menotti, +13

Cancer Research

Hypoxia-inducible FactorsPathologyCancer BiologyTumor BiologyAlk-dependent Control +16

STAT3-mediated activation of microRNA cluster 17 92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma

Elisa Spaccarotella, Elisa Pellegrino, Manuela Ferracin, +13

Haematologica